The additional pressure-lowering effect in patients with glaucoma of pilocarpine 2 per cent, adrenaline 1 per cent, or guanethidine 3 per cent with adrenaline 0.5 per cent and timolol 0.25 per cent: a double-blind cross-over study
- PMID: 6385355
The additional pressure-lowering effect in patients with glaucoma of pilocarpine 2 per cent, adrenaline 1 per cent, or guanethidine 3 per cent with adrenaline 0.5 per cent and timolol 0.25 per cent: a double-blind cross-over study
Abstract
A group of twelve comparable patients with primary open angle glaucoma were treated with Timolol 0.25 per cent drops to which was added pilocarpine 2 per cent, adrenaline 1 per cent or guanethidine 3 per cent plus adrenaline 0.5 per cent in a cross-over study. The initial intraocular pressure (IOP) reduction due to timolol was statistically significant. The mean additional IOP lowering due to pilocarpine 2 per cent was 1.37 mm Hg, that due to adrenaline 1 per cent was 1.79 mm Hg and that due to guanethidine 3 per cent plus adrenaline 0.5 per cent was 5.29 mm Hg.
Similar articles
-
Two blind randomized cross-over trials in the treatment of primary open angle glaucoma.Trans Ophthalmol Soc U K (1962). 1981;101 (Pt 4):397-402. Trans Ophthalmol Soc U K (1962). 1981. PMID: 6764321 Clinical Trial.
-
Timolol and guanethidine plus adrenaline in combination in the treatment of chronic open angle glaucoma.Trans Ophthalmol Soc U K (1962). 1985;104 ( Pt 6):621-4. Trans Ophthalmol Soc U K (1962). 1985. PMID: 3866411 Clinical Trial.
-
[Treatment of glaucoma chronicum simplex with a combination of 0.5 percent timolol with 0.5 percent adrenaline plus 0.3 percent guanethidine].Klin Monbl Augenheilkd. 1989 Mar;194(3):161-3. doi: 10.1055/s-2008-1046354. Klin Monbl Augenheilkd. 1989. PMID: 2657199 Clinical Trial. German.
-
Treatment of glaucoma.Annu Rev Med. 1984;35:195-205. doi: 10.1146/annurev.me.35.020184.001211. Annu Rev Med. 1984. PMID: 6426371 Review.
-
Initial treatment of glaucoma: surgery or medications.Surv Ophthalmol. 1993 Jan-Feb;37(4):293-305. doi: 10.1016/0039-6257(93)90013-w. Surv Ophthalmol. 1993. PMID: 8441955 Review.